Back

SPIRRIT-HFpEF: spironolactone versus usual care in HFpEF.

31 August 2020 (12:26 - 12:40)
Organised by:
Congress Presentation Part of: Pragmatic Cardiovascular Trials - A New Approach to Generating Evidence Trial Design ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

2 More presentations in this session

Presentation thumbnail
Aspirin dosing for secondary prevention - The ADAPTABLE trial.
Professor A. Hernandez (Durham, US)
Video
Presentation thumbnail
ABC AF Study: risk score-guided versus standard care in atrial fibrillation.
Professor J. Oldgren (Uppsala, SE)
Video

Access the full session

Session thumbnail
Pragmatic Cardiovascular Trials - A New Approach to Generating Evidence

The Event

Event poster

ESC Congress 2020

31 August 2020 12:26 CET
You may be interested in
thumbnail
Congress Session
Improving patient outcomes in heart failure: the role of finerenone
19 May 2025
thumbnail
Congress Session
Clinical perspectives on heart failure management
18 May 2025
thumbnail
Congress Presentation
Sex-based differences in treatment outcomes in HFpEF: a systematic review
28 August 2022
thumbnail
ESC Journals
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial
20 November 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources